INsTRuCT Consortium

A network of European scientists from academic and industry focused on developing innovative myeloid regulatory cell (MRC)-based immunotherapies.

INsTRuCT was conceived as a platform for accelerating translation of basic scientific advances in MRC-based therapy into viable pharmaceutical products. The structure of the consortium reflects this ambition, amalgamating excellence in basic, applied and clinical science with expertise from the commercial sector.



The INsTRuCT consortium brings together existing collaborators and several important new partners as a well-balanced and scientifically complementary network.